Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 1
1985 1
1986 4
1987 4
1988 5
1989 8
1990 6
1991 8
1992 10
1993 14
1994 6
1995 6
1996 9
1997 5
1998 13
1999 9
2000 6
2001 7
2002 6
2003 8
2004 5
2005 5
2006 7
2007 2
2008 4
2009 2
2010 1
2011 9
2012 2
2013 1
2014 3
2015 2
2016 3
2017 3
2018 2
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

181 results
Results by year
Filters applied: . Clear all
Page 1
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial.
Coleman RL, Brady MF, Herzog TJ, Sabbatini P, Armstrong DK, Walker JL, Kim BG, Fujiwara K, Tewari KS, O'Malley DM, Davidson SA, Rubin SC, DiSilvestro P, Basen-Engquist K, Huang H, Chan JK, Spirtos NM, Ashfaq R, Mannel RS. Coleman RL, et al. Among authors: rubin sc. Lancet Oncol. 2017 Jun;18(6):779-791. doi: 10.1016/S1470-2045(17)30279-6. Epub 2017 Apr 21. Lancet Oncol. 2017. PMID: 28438473 Free PMC article. Clinical Trial.
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer.
Chan JK, Brady MF, Penson RT, Huang H, Birrer MJ, Walker JL, DiSilvestro PA, Rubin SC, Martin LP, Davidson SA, Huh WK, O'Malley DM, Boente MP, Michael H, Monk BJ. Chan JK, et al. Among authors: rubin sc. N Engl J Med. 2016 Feb 25;374(8):738-48. doi: 10.1056/NEJMoa1505067. N Engl J Med. 2016. PMID: 26933849 Free PMC article. Clinical Trial.
Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, DiSilvestro PA, Fujiwara K, Alberts DS, Zheng W, Tewari KS, Cohn DE, Powell MA, Van Le L, Davidson SA, Gray HJ, Rose PG, Aghajanian C, Myers T, Alvarez Secord A, Rubin SC, Mannel RS. Walker JL, et al. Among authors: rubin sc. J Clin Oncol. 2019 Jun 1;37(16):1380-1390. doi: 10.1200/JCO.18.01568. Epub 2019 Apr 19. J Clin Oncol. 2019. PMID: 31002578 Free PMC article. Clinical Trial.
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.
Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G. Zhang L, et al. Among authors: rubin sc. N Engl J Med. 2003 Jan 16;348(3):203-13. doi: 10.1056/NEJMoa020177. N Engl J Med. 2003. PMID: 12529460 Free article.
Prophylactic oophorectomy.
Coukos G, Rubin SC. Coukos G, et al. Among authors: rubin sc. Best Pract Res Clin Obstet Gynaecol. 2002 Aug;16(4):597-609. doi: 10.1053/beog.2002.9305. Best Pract Res Clin Obstet Gynaecol. 2002. PMID: 12413937 Review.
Early ovarian cancer.
Coukos G, Rubin SC. Coukos G, et al. Among authors: rubin sc. Curr Treat Options Oncol. 2000 Jun;1(2):129-37. doi: 10.1007/s11864-000-0057-2. Curr Treat Options Oncol. 2000. PMID: 12057050 Review.
Surgery for ovarian cancer.
Rubin SC. Rubin SC. Hematol Oncol Clin North Am. 1992 Aug;6(4):851-65. Hematol Oncol Clin North Am. 1992. PMID: 1380000 Review.
Treatment of uterine leiomyosarcoma.
Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr. Berchuck A, et al. Among authors: rubin sc. Obstet Gynecol. 1988 Jun;71(6 Pt 1):845-50. Obstet Gynecol. 1988. PMID: 2453004 Review.
BRCA-related ovarian carcinoma.
Rubin SC. Rubin SC. Cancer. 2003 May 1;97(9):2127-9. doi: 10.1002/cncr.11341. Cancer. 2003. PMID: 12712461 Free article. No abstract available.
Surgical management of ovarian cancer.
Randall TC, Rubin SC. Randall TC, et al. Among authors: rubin sc. Semin Surg Oncol. 1999 Oct-Nov;17(3):173-80. doi: 10.1002/(sici)1098-2388(199910/11)17:3<173::aid-ssu6>3.0.co;2-5. Semin Surg Oncol. 1999. PMID: 10504665 Review.
181 results